Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Johann Wolfgang Goethe University Hospitals |
---|---|
Information provided by: | Johann Wolfgang Goethe University Hospitals |
ClinicalTrials.gov Identifier: | NCT00593762 |
The purpose of the study is to determine the response to aspirin (ASA) and Clopidogrel in patients with peripheral arterial occlusive disease (PAOD) requiring interventional procedures and to investigate if patients with "resistance" to ASA or Clopidogrel have an unfavourable outcome during long-term follow-up
Condition |
---|
Peripheral Arterial Occlusive Disease |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Investigation of Laboratory Resistance to Aspirin and Clopidogrel and Its Clinical Relevance in Patients With Peripheral Arterial Occlusive Disease Requiring Interventional Procedures |
Whole blood, serum
Estimated Enrollment: | 200 |
Study Start Date: | May 2005 |
Estimated Study Completion Date: | December 2009 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 85 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
patients with peripheral arterial occlusive disease (PAOD) requiring a catheter interventional procedure
Inclusion Criteria:
Exclusion Criteria:
Germany, Hessen | |
Division of Vascular Medicine, Department of Internal Medicine, J.W.Goethe University Hospital | Recruiting |
Frankfurt/Main, Hessen, Germany, D-60590 | |
Contact: Birgit Linnemann, MD +49 69 6301 5096 Birgit.Linnemann@kgu.de |
Principal Investigator: | Birgit Linnemann, MD | Division of Vascular Medicine, Department of Internal Medicine, J.W. Goethe University Hospital Frankfurt |
Responsible Party: | Division of Vascular Medicine, Department of Internal Medicine, J.W.Goethe University Hospital Frankfurt ( PD Dr. E. Lindhoff-Last ) |
Study ID Numbers: | E 19/05 |
Study First Received: | January 3, 2008 |
Last Updated: | January 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00593762 History of Changes |
Health Authority: | Germany: Ethics Commission |
Peripheral arterial occlusive disease Aspirin Clopidogrel |
Resistance Catheter interventional procedure ASA and clopidogrel resistance |
Arterial Occlusive Diseases Aspirin Clopidogrel Vascular Diseases Platelet Aggregation Inhibitors |
Arterial Occlusive Diseases Therapeutic Uses Clopidogrel Hematologic Agents |
Vascular Diseases Platelet Aggregation Inhibitors Cardiovascular Diseases Pharmacologic Actions |